Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 125OTHER_GOV 2NETWORK 2NIH 1INDUSTRY 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2Thoracic 1Plasma cell 1Gastrointestinal 1

Conditions

Multiple Myeloma 1Lung Neoplasms 1Gastrointestinal Neoplasms 1Breast Neoplasms 1

Interventions

Gemcitabine 302Fluorouracil 296Oxaliplatin 269Bevacizumab 267Capecitabine 233Leucovorin 229pembrolizumab 215Irinotecan 185Cisplatin 142Cetuximab 142Nivolumab 131Paclitaxel 117130-nm albumin-bound paclitaxel 117Sorafenib 86Albumin-Bound Paclitaxel 75Docetaxel 65regorafenib 64atezolizumab 64IFL protocol 61Folfox protocol 61Trastuzumab 55Panitumumab 47durvalumab 46Ramucirumab 43Injections 43Sunitinib 41Drug Therapy 41Carboplatin 40trifluridine tipiracil drug combination 38lenvatinib 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Surveys and Questionnaires × Gastrointestinal × Clear all
NCT05587972 2026-02-23

Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring

Carevive Systems, Inc.

Phase NA Active not recruiting
100 enrolled
BreastGastrointestinalPlasma cellThoracic

Breast Neoplasms, Gastrointestinal Neoplasms, Lung Neoplasms, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡